22 research outputs found

    Π˜Π·ΡƒΡ‡Π΅Π½ΠΈΠ΅ адсорбции тСхнСция-99ΠΌ Π½Π° оксидС алюминия ΠΈΠ· срСды мСтилэтилкСтона Π² статичСских ΠΈ динамичСских условиях

    Get PDF
    ИсслСдована адсорбция экстрагированного мСтилэтилкСтоном 99mВс Π½Π° Π³Π°ΠΌΠΌΠ°-оксидС алюминия с Ρ€Π°Π·Π»ΠΈΡ‡Π½ΠΎΠΉ рН-Ρ„ΠΎΡ€ΠΌΠΎΠΉ Π² статичСских ΠΈ динамичСских условиях провСдСния процСсса. ΠžΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Ρ‹ коэффициСнты распрСдСлСния 99mВс Π² систСмС мСтилэтилкСтон - 99mВс - оксид алюминия. УстановлСно, Ρ‡Ρ‚ΠΎ максимальная сорбционная Π΅ΠΌΠΊΠΎΡΡ‚ΡŒ ΠΏΠΎ Ρ€Π°Π΄ΠΈΠΎΠ½ΡƒΠΊΠ»ΠΈΠ΄Ρƒ достигаСтся Π½Π° оксидах с рН-Ρ„ΠΎΡ€ΠΌΠΎΠΉ 4,5_6. Π’ этих ΠΆΠ΅ условиях Π½Π°Π±Π»ΡŽΠ΄Π°ΡŽΡ‚ΡΡ наимСньшиС ΠΏΠΎΡ‚Π΅Ρ€ΠΈ 99mВс ΠΏΡ€ΠΈ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Π΅Π³ΠΎ адсорбции Π½Π° хроматографичСской ΠΊΠΎΠ»ΠΎΠ½ΠΊΠ΅ ΠΈ ΠΏΡ€ΠΎΠΌΡ‹Π²ΠΊΠ΅ ΠΊΠΎΠ»ΠΎΠ½ΠΊΠΈ Π²ΠΎΠ΄ΠΎΠΉ, Π° Ρ‚Π°ΠΊΠΆΠ΅ наибольший Π²Ρ‹Ρ…ΠΎΠ΄ 99mВс (Π±ΠΎΠ»Π΅Π΅ 95 %) ΠΏΡ€ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅ΠΌ Π΅Π³ΠΎ Π²Ρ‹Π΄Π΅Π»Π΅Π½ΠΈΠΈ Π² Π²ΠΈΠ΄Π΅ раствора натрия ΠΏΠ΅Ρ€Ρ‚Π΅Ρ…Π½Π΅Ρ‚Π°Ρ‚Π°,99mВс. Показано, Ρ‡Ρ‚ΠΎ общая ΠΏΡ€ΠΎΠ΄ΠΎΠ»ΠΆΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ процСсса отдСлСния 99mВс ΠΎΡ‚ экстрагСнта Π½Π΅ ΠΏΡ€Π΅Π²Ρ‹ΡˆΠ°Π΅Ρ‚ 20 ΠΌΠΈΠ½, Ρ‡Ρ‚ΠΎ сопоставимо с Π²Ρ€Π΅ΠΌΠ΅Π½Π΅ΠΌ получСния ΡΠ»ΡŽΠ°Ρ‚Π° 99mВс ΠΈΠ· Ρ‚Ρ€Π°Π΄ΠΈΡ†ΠΈΠΎΠ½Π½Ρ‹Ρ… сорбционных Π³Π΅Π½Π΅Ρ€Π°Ρ‚ΠΎΡ€ΠΎΠ², ΠΈ, Π² ΠΊΠΎΠ½Π΅Ρ‡Π½ΠΎΠΌ ΠΈΡ‚ΠΎΠ³Π΅, обСспСчиваСт Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ‚ΡŒ создания рСсурсоэффСктивных экологичСски чистых производств Ρ€Π°Π΄ΠΈΠΎΡ„Π°Ρ€ΠΌΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ² 99mВс

    Clinical course of untreated cerebral cavernous malformations: A meta-analysis of individual patient data

    Get PDF
    SummaryBackgroundCerebral cavernous malformations (CCMs) can cause symptomatic intracranial haemorrhage (ICH), but the estimated risks are imprecise and predictors remain uncertain. We aimed to obtain precise estimates and predictors of the risk of ICH during untreated follow-up in an individual patient data meta-analysis.MethodsWe invited investigators of published cohorts of people aged at least 16 years, identified by a systematic review of Ovid MEDLINE and Embase from inception to April 30, 2015, to provide individual patient data on clinical course from CCM diagnosis until first CCM treatment or last available follow-up. We used survival analysis to estimate the 5-year risk of symptomatic ICH due to CCMs (primary outcome), multivariable Cox regression to identify baseline predictors of outcome, and random-effects models to pool estimates in a meta-analysis.FindingsAmong 1620 people in seven cohorts from six studies, 204 experienced ICH during 5197 person-years of follow-up (Kaplan-Meier estimated 5-year risk 15Β·8%, 95% CI 13Β·7–17Β·9). The primary outcome of ICH within 5 years of CCM diagnosis was associated with clinical presentation with ICH or new focal neurological deficit (FND) without brain imaging evidence of recent haemorrhage versus other modes of presentation (hazard ratio 5Β·6, 95% CI 3Β·2–9Β·7) and with brainstem CCM location versus other locations (4Β·4, 2Β·3–8Β·6), but age, sex, and CCM multiplicity did not add independent prognostic information. The 5-year estimated risk of ICH during untreated follow-up was 3Β·8% (95% CI 2Β·1–5Β·5) for 718 people with non-brainstem CCM presenting without ICH or FND, 8Β·0% (0Β·1–15Β·9) for 80 people with brainstem CCM presenting without ICH or FND, 18Β·4% (13Β·3–23Β·5) for 327 people with non-brainstem CCM presenting with ICH or FND, and 30Β·8% (26Β·3–35Β·2) for 495 people with brainstem CCM presenting with ICH or FND.InterpretationMode of clinical presentation and CCM location are independently associated with ICH within 5 years of CCM diagnosis. These findings can inform decisions about CCM treatment.FundingUK Medical Research Council, Chief Scientist Office of the Scottish Government, and UK Stroke Association

    The contribution of imaging in diagnosis, preoperative assessment, and follow-up of moyamoya disease : a review

    No full text
    none6The aim of this review was to evaluate the imaging tools used in diagnosis and perioperative assessment of moyamoya disease, with particular attention to the last decade.mixedBacigaluppi S.; Dehdashti A.R.; Agid R.; Krings T.; Tymianski M.; Mikulis D.J.Bacigaluppi, S.; Dehdashti, A. R.; Agid, R.; Krings, T.; Tymianski, M.; Mikulis, D. J

    Thrombectomy for Distal, Medium Vessel Occlusions

    No full text
    Endovascular thrombectomy (EVT) is well established as a highly effective treatment for acute ischemic stroke (AIS) due to proximal, large vessel occlusions (PLVOs). With iterative further advances in catheter technology, distal, medium vessel occlusions (DMVOs) are now emerging as a promising next potential EVT frontier. This consensus statement integrates recent epidemiological, anatomic, clinical, imaging, and therapeutic research on DMVO-AIS and provides a framework for further studies. DMVOs cause 25% to 40% of AISs, arising as primary thromboemboli and as unintended consequences of EVT performed for PLVOs, including emboli to new territories (ENTs) and emboli to distal territories (EDTs) within the initially compromised arterial field. The 6 distal medium arterial arbors (anterior cerebral artery [ACA], M2–M4 middle cerebral artery [MCA], posterior cerebral artery [PCA], posterior inferior cerebellar artery [PICA], anterior inferior cerebellar artery [AICA], and superior cerebellar artery [SCA]) typically have 25 anatomic segments and give rise to 34 distinct arterial branches nourishing highly differentiated, largely superficial cerebral neuroanatomical regions. DMVOs produce clinical syndromes that are highly heterogenous but frequently disabling. While intravenous fibrinolytics are more effective for distal than proximal occlusions, they fail to recanalize one-half to two-thirds of DMVOs. Early clinical series using recently available, smaller, more navigable stent retriever and thromboaspiration devices suggest EVT for DMVOs is safe, technically efficacious, and potentially clinically beneficial. Collaborative investigations are desirable to enhance imaging recognition of DMVOs; advance device design and technical efficacy; conduct large registry studies using harmonized, common data elements; and complete formal randomized trials, improving treatment of this frequent mechanism of stroke

    Imaging diagnosis and the role of endovascular embolization treatment for vascular intraspinal tumors

    No full text
    Intraspinal tumors comprise a large spectrum of neoplasms, including hemangioblastomas, paragangliomas, and meningiomas. These tumors have several common characteristic imaging features, such as highly vascular mass appearance in angiography, hypointense rim and serpentine flow voids in MRI, and intense enhancement after intravenous contrast administration. Due to their rich vascularity, these tumors represent a special challenge for surgical treatment. More recently, the surgical treatment of intraspinal vascular tumors has benefited from the combination of endovascular techniques used to better delineate these lesions and to promote preoperative reduction of volume and tissue blood flow. Endovascular embolization has been proven to be a safe procedure that facilitates the resection of these tumors; hence, it has been proposed as part of the standard of care in their management

    Absence of pontine perforators in vertebrobasilar dolichoectasia on ultra-high resolution cone-beam computed tomography.

    Get PDF
    BACKGROUND Vertebrobasilar dolichoectasia (VBDE) is a rare type of non-saccular intracranial aneurysm, with poor natural history and limited effective treatment options. Visualizing neurovascular microanatomy in patients with VBDE has not been previously reported, but may yield insight into the pathology, and provide important information for treatment planning. OBJECTIVE To carry out a retrospective analysis of ultra-high resolution cone-beam computed tomography (UHR-CBCT) in patients with fusiform basilar aneurysms, visualizing neurovascular microanatomy of the posterior circulation with a special focus on the pontine perforators. METHODS UHR-CBCT was performed in seven patients (mean age 59 years; two female) with a VBDE, and in 14 control patients with unrelated conditions. RESULTS The mean maximum diameter of the fusiform vessel segment was 28 mm (range 19-36 mm), and the mean length of the segment was 39 mm (range 15-50 mm). In all patients with VBDE, UHR-CBCT demonstrated an absence of perforating arteries in the fusiform arterial segment and a mean of 3.7 perforators arising from the unaffected vessel segment. The network of interconnected superficial circumferential pontine arteries (brainstem vasocorona) were draping around the aneurysm sac. In controls, a mean of 3.6, 2.5, and 1.2 perforators were demonstrated arising from the distal, mid-, and proximal basilar artery, respectively. CONCLUSIONS The absence of pontine perforators in the fusiform vessel segment of VBDE is counterbalanced by recruitment of collateral flow from pontine perforators arising from the unaffected segment of the basilar artery, as well as collaterals arising from the anterior inferior cerebellar artery/posterior inferior cerebellar artery and superior cerebellar artery. These alternative routes supply the superficial brainstem arteries (brainstem vasocorona) and sustain brainstem viability. Our findings might have implications for further treatment planning

    Clinical, radiological, and flow-related risk factors for growth of untreated, unruptured intracranial aneurysms

    No full text
    BACKGROUND AND PURPOSE: Unruptured intracranial aneurysms are frequently followed to monitor aneurysm growth. We studied the yield of follow-up imaging and analyzed risk factors for aneurysm growth. METHODS: We included patients with untreated, unruptured intracranial aneurysms and β‰₯6 months of follow-up imaging from 2 large prospectively collected databases. We assessed the proportion of patients with aneurysm growth and performed univariable and multivariable Cox regression analyses to calculate hazard ratios with corresponding 95% confidence intervals (CI) for clinical and radiological risk factors for aneurysm growth. We repeated these analyses for the subset of small ( neck ratio; 2.1 (95% CI, 0.9-4.9) for location in the posterior circulation; and 2.0 (95% CI, 0.8-4.8) for multilobarity. In the subset of aneurysms <7 mm, 37 of 403 (9%) enlarged. In multivariable analysis, hazard ratios for aneurysm growth were 1.1 (95% CI, 0.8-1.5) per each additional mm of initial aneurysm size, 2.2 (95% CI, 1.0-4.8) for smoking, 2.9 (95% CI, 1.0-8.5) for multilobarity, 2.4 (95% CI, 1.0-5.8) for dome/neck ratio, and 2.0 (95% CI, 0.6-7.0) for location in the posterior circulation. CONCLUSIONS: Initial aneurysm size, dome/neck ratio, and multilobarity are risk factors for aneurysm growth. Cessation of smoking is pivotal because smoking is a modifiable risk factor for growth of small aneurysms

    Clinical, radiological, and flow-related risk factors for growth of untreated, unruptured intracranial aneurysms

    No full text
    BACKGROUND AND PURPOSE: Unruptured intracranial aneurysms are frequently followed to monitor aneurysm growth. We studied the yield of follow-up imaging and analyzed risk factors for aneurysm growth. METHODS: We included patients with untreated, unruptured intracranial aneurysms and β‰₯6 months of follow-up imaging from 2 large prospectively collected databases. We assessed the proportion of patients with aneurysm growth and performed univariable and multivariable Cox regression analyses to calculate hazard ratios with corresponding 95% confidence intervals (CI) for clinical and radiological risk factors for aneurysm growth. We repeated these analyses for the subset of small ( neck ratio; 2.1 (95% CI, 0.9-4.9) for location in the posterior circulation; and 2.0 (95% CI, 0.8-4.8) for multilobarity. In the subset of aneurysms <7 mm, 37 of 403 (9%) enlarged. In multivariable analysis, hazard ratios for aneurysm growth were 1.1 (95% CI, 0.8-1.5) per each additional mm of initial aneurysm size, 2.2 (95% CI, 1.0-4.8) for smoking, 2.9 (95% CI, 1.0-8.5) for multilobarity, 2.4 (95% CI, 1.0-5.8) for dome/neck ratio, and 2.0 (95% CI, 0.6-7.0) for location in the posterior circulation. CONCLUSIONS: Initial aneurysm size, dome/neck ratio, and multilobarity are risk factors for aneurysm growth. Cessation of smoking is pivotal because smoking is a modifiable risk factor for growth of small aneurysms
    corecore